Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Minnesota |
---|---|
Information provided by: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT00880685 |
The goal of the proposed study is to evaluate the efficacy and safety of memantine in kleptomania.
Condition | Intervention | Phase |
---|---|---|
Kleptomania |
Drug: Memantine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Memantine Treatment of Kleptomania: An Open-Label Study |
Estimated Enrollment: | 10 |
Study Start Date: | March 2009 |
Estimated Study Completion Date: | May 2010 |
Estimated Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Memantine: Experimental
Memantine 10-30mg
|
Drug: Memantine
10-30mg, daily for 8 weeks
|
The proposed study will consist of 8 weeks of treatment with memantine in 10 subjects with kleptomania. The hypothesis to be tested is that memantine will be effective in reducing the urges to steal in patients with kleptomania. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Brian L Odlaug, BA | 612-627-4363 | odla0019@umn.edu |
Contact: Jon E Grant, MD, JD | 612-273-9736 | grant045@umn.edu |
United States, Minnesota | |
University of Minnesota | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Brian L Odlaug, BA 612-627-4363 odla0019@umn.edu | |
Contact: Jon E Grant, MD, JD 612-273-9736 grant045@umn.edu | |
Principal Investigator: Jon E Grant, MD | |
Sub-Investigator: S W Kim, MD |
Principal Investigator: | Jon E Grant, MD, JD | University of Minnesota |
Responsible Party: | University of Minnesota ( Jon E Grant, MD, JD ) |
Study ID Numbers: | 0901M56882 |
Study First Received: | March 18, 2009 |
Last Updated: | April 10, 2009 |
ClinicalTrials.gov Identifier: | NCT00880685 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Compulsive Stealing Compulsive Shoplifting |
Excitatory Amino Acids Neurotransmitter Agents Impulse Control Disorders Dopamine |
Mental Disorders Memantine Dopamine Agents |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Physiological Effects of Drugs Antiparkinson Agents Excitatory Amino Acid Agents Pharmacologic Actions |
Impulse Control Disorders Mental Disorders Therapeutic Uses Memantine Dopamine Agents Central Nervous System Agents Excitatory Amino Acid Antagonists |